Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2137218 | Leukemia Research | 2013 | 6 Pages |
Abstract
Relevance of immune-dysregulation for emergence, dominance and progression of dysplastic clones in myelodysplastic syndromes (MDS) was suggested, but valuable or predictive criteria on this involvement are lacking.We previously reported that reduced T-regulatory cells (Treg) and high CD54 expression on T cell identify a sub-group of patients in whom an immune-pathogenesis might be inferred.Here, we suggest the occurrence of immune-selection of dysplastic clones in a subgroup of MDS patients, with reduced HLA-I and HLA-E on PMN, and propose that an altered immune profile might represent a valuable criterion to classify Low/Int-1 patients on the basis of immune-pathogenesis of MDS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Giuseppe Terrazzano, Fiorella Alfinito, Anna Teresa Palatucci, Valentina Rubino, Roberta Della Pepa, Angela Giovazzino, Giuseppina Ruggiero,